1-3 of 3
Gene G. Kinney, PhD
Close
Sort by
Journal Articles

The VITAL Amyloidosis Study: A Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study of NEOD001 in Patients with AL Amyloidosis and Cardiac Dysfunction

Michaela Liedtke, MD, Giampaolo Merlini, MD, Heather Landau, MD, Raymond L. Comenzo, MD, Vaishali Sanchorawala, MD, Brendan M. Weiss, MD, Jeffrey A. Zonder, MD, Jackie Walling, MBChB, PhD, Gene G. Kinney, PhD, Martin Koller, MD MPH, Morie A. Gertz, MD MACP
Journal: Blood
Blood (2016) 128 (22): 5690.
https://doi.org/10.1182/blood.V128.22.5690.5690
Published: 2016
Journal Articles

Organ Biomarker Responses in Patients with Light Chain Amyloidosis Treated with NEOD001 Are Independent of Previous Hematologic Response

Michaela Liedtke, MD, Raymond L. Comenzo, MD, Heather Landau, MD, Vaishali Sanchorawala, MD, Brendan M. Weiss, MD, Jeffrey A. Zonder, MD, Jackie Walling, MBChB, PhD, Gene G. Kinney, PhD, Martin Koller, MD MPH, Dale B. Schenk, PhD, Spencer D. Guthrie, MBA, Enchi Liu, PhD, Morie A. Gertz, MD MACP
Journal: Blood
Blood (2016) 128 (22): 647.
https://doi.org/10.1182/blood.V128.22.647.647
Published: 2016
Journal Articles

NEOD001 Demonstrates Organ Biomarker Responses in Patients with Light Chain Amyloidosis and Persistent Organ Dysfunction: Results from the Expansion Cohort of a Phase 1/2 Study

Morie A. Gertz, MD MACP, Raymond L. Comenzo, MD, Heather Landau, MD, Vaishali Sanchorawala, MD, Brendan M. Weiss, MD, Jeffrey A. Zonder, MD, Jackie Walling, MBChB, PhD, Gene G. Kinney, PhD, Martin Koller, MD MPH, Dale B. Schenk, PhD, Spencer D. Guthrie, MBA, Enchi Liu, PhD, Michaela Liedtke, MD
Journal: Blood
Blood (2016) 128 (22): 644.
https://doi.org/10.1182/blood.V128.22.644.644
Published: 2016